Stockscreener 앱 받기
8.48
2.54%
0.21
시간 외 거래:
8.52
0.04
+0.47%
전일 마감가:
$8.27
열려 있는:
$8.38
하루 거래량:
2.39M
Relative Volume:
0.54
시가총액:
$1.97B
수익:
$509.86M
순이익/손실:
$165.35M
주가수익비율:
12.51
EPS:
0.6779
순현금흐름:
$107.55M
1주 성능:
-3.09%
1개월 성능:
-3.09%
6개월 성능:
-48.85%
1년 성능:
-52.92%
1일 변동 폭
$8.35
$8.62
1주일 범위
$8.165
$8.755
52주 변동 폭
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
8.48 | 1.92B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | Canaccord Genuity | Buy |
| 2026-03-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
DEADLINE ALERT for VIA, Z, ADMA, and ERAS: The Law Offices - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV
ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff - GlobeNewswire
Did You Lose Money Investing in ADMA Biologics, Inc. - GlobeNewswire
ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed - Morningstar
AUGUST 10, 2026 DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead ADMA Investor Class Action Lawsuit - TMX Newsfile
$ADMA Lawsuit Notice: BFA Law Reminds ADMA Biologics - GlobeNewswire
August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA) – Contact Levi & Korsinsky - ACCESS Newswire
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits
Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action - ACCESS Newswire
ADMA Biologics Inc (ADMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Supply Chain Digital
August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA)Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on ADMA Biologics, Inc. (ADMA)? Urged to Join Class Action Before August 10, 2026Contact Levi & Korsinsky - ACCESS Newswire
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc.ADMA - PR Newswire
What Are the Allegations Against ADMA Biologics - Kavout | AI
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
ADMA Biologics Inc (ADMA) Cash Flow - TradingKey
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities - GlobeNewswire
ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS - PR Newswire
ADMA|ADMA Biologics Inc|Price:8.375|Chg%:-0.005 - TradingKey
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA Biologics Inc (ADMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ADMA - The National Law Review
ADMA BIOLOGICS CLASS ACTION REMINDER: Bragar Eagel & - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - Caledonian Record
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the ... - Caledonian Record
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking RecoveryContact SueWallSt - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
ADMA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ADMA Biologics Inc|Price:8.270 - TradingKey
How (ADMA) Movements Inform Risk Allocation Models - Stock Traders Daily
ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors - GlobeNewswire
ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Conway Daily Sun
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and Mail
ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to ... - Caledonian Record
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026 - PR Newswire
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors - GlobeNewswire
ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
Form 4 ADMA Biologics Inc For: 21 July By Investing.com - Investing.com South Africa
ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action - PR Newswire
ADMA Biologics Faces Securities Class Action Over Disclosure Failures - Intellectia AI
ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities - GlobeNewswire
ADMA Biologics Inc (ADMA): Navigating A Biotech Growth Path With A 95% Upside Potential - DirectorsTalk Interviews
ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. ... - Caledonian Record
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):